Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colgate Total is a commercially available toothpaste developed by Colgate Palmolive. It is formulated with 0.32% sodium fluoride (1450 ppm NaF) and 0.3% triclosan. Sodium fluoride primarily works by interacting with hydroxyapatite in tooth enamel, converting it to fluorapatite, which is more resistant to acid dissolution and enhances remineralization, thereby preventing dental caries. It also exerts antimicrobial effects by inhibiting bacterial enzymes like enolase. Triclosan acts as an antibacterial agent by inhibiting bacterial fatty acid synthesis, specifically targeting the enzyme enoyl-acyl carrier protein reductase (FabI), which is crucial for bacterial cell membrane formation and integrity. The toothpaste is indicated for controlling gingivitis and dental plaque.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Colgate Total.